10 Best New Penny Stocks to Buy

2. AtaiBeckley Inc. (NASDAQ:ATAI)

AtaiBeckley Inc. (NASDAQ:ATAI) is one of the best new penny stocks to buy. On March 6, AtaiBeckley reported full-year 2025 earnings, which were highlighted by the pivotal execution phase following the strategic combination of Atai Life Sciences and Beckley Psytech and its subsequent US redomiciliation. A primary focus is the BPL-003 nasal spray for treatment-resistant depression/TR, which is on track to initiate a Phase 3 pivotal program in Q2 2026. This program, supported by the FDA, will include two major studies, ReConnection-1 and ReConnection-2, with topline results anticipated by early 2029.

The company also reported positive clinical progress across its broader pipeline, including the VLS-01 buccal film and EMP-01 for Social Anxiety Disorder/SAD. VLS-01 is expected to yield Phase 2 topline data in H2 2026. Meanwhile, an exploratory Phase 2a trial of EMP-01 successfully met its primary safety objectives and showed clinically meaningful improvements in efficacy measures. To protect these innovations, AtaiBeckley secured a new US patent for EMP-01, extending its expected exclusivity through 2043.

AtaiBeckley Inc. (NASDAQ:ATAI) ended 2025 with $220.7 million in cash, cash equivalents, and short-term securities driven by equity-related issuances. While the company reported a net loss of $660 million for the full year, largely due to a $530 million non-cash charge related to the Beckley Psytech acquisition, it maintains a strong capital position. Management expects current liquidity to fund operations into early 2029, covering the timeline for its major Phase 3 readouts.

AtaiBeckley Inc. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company that researches, develops, and commercializes mental health treatments in the US, Germany, and Canada.